Skip to main content

Animations

MJFF Publications

5081 - 5090 of 8715 Results
Title
Year
  • Year
  • 2021
  • 2019
  • 2025
  • 2020
  • 2020
  • 2018
  • 2016
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Palliative Care and Parkinson's Disease: Time to Move Beyond Cancer
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28556
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Journal Name: Molecular Genetics and Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ymgme.2019.10.001
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Harmonization of Structural Brain Connectivity Through Distribution Matching
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/hbm.70257
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a‐synuclein in mouse brain
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.15199
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Impact of Overweight and Obesity on Functional and Clinical Outcomes of Early Parkinson's Disease
    Journal Name: Journal of the American Medical Directors Association
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jamda.2019.11.019
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Parkinson’S Disease is Ready for Precision Medicine
    Journal Name: Personalized Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/pme-2016-0052
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00840-w
    Citation Count: 1
  • Summary Details
    OPEN
    Title: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkae776
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.